GENOCEA BIOSCIENCES, INC. - 372427104

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q2 2014 · Q1 2014
Value (USD)
Total reported value ($000)
$45.02M
QoQ value delta ($000)
-$62.65M (-58.19%)
Implied price effect (QoQ)
+3.08%
Shares
Total shares
2,400,959
QoQ shares delta
-3,518,550 (-59.44%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Top holders (Q2 2014)

Top 25 only Full list
Early Q3 2018 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Polaris Venture Management Co. V, L.L.C. 39,913 2,128,678 32.52%
BlackRock Fund Advisors 1,829 97,542 0.0%
VANGUARD GROUP INC 1,701 90,697 0.0%
BlackRock Institutional Trust Company, N.A. 965 51,446 0.0%
BlackRock Investment Management, LLC 224 11,935 0.0%
BANQUE PICTET & CIE SA 218 11,606 0.01%
Nationwide Fund Advisors 58 3,084 0.0%
BLACKROCK ADVISORS LLC 56 2,983 0.0%
AMERICAN INTERNATIONAL GROUP INC 47 2,555 0.0%
RidgeWorth Capital Management LLC 6 333 0.0%
PNC FINANCIAL SERVICES GROUP, INC. 2 100 0.0%